|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 16/09/14 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 04/09/14 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Executive Committee: InterMune Inc
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 71 | 01/04/2002 | |
Carla Fiankan
LAW | General Counsel | - | 01/08/2011 |
Company details: InterMune Inc
Other Biotechnology & Medical Research
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.84% | -0.74% | +3.78% | +15.46% | 48.57B | |
| +0.41% | +3.78% | +443.85% | +572.84% | 41.95B | |
| -2.68% | -3.18% | +29.72% | +4.99% | 38.85B | |
| -0.02% | +1.90% | +9.94% | +75.02% | 37.24B | |
| +2.47% | +8.33% | +15.16% | +48.37% | 30.67B | |
| -1.20% | +0.50% | +35.05% | +123.20% | 16.41B | |
| +2.27% | -0.47% | - | - | 16.1B | |
| +0.29% | +1.87% | +8.17% | +19.01% | 13.97B | |
| -1.29% | -3.21% | +3.08% | -36.32% | 12.62B | |
| Average | +0.13% | -0.30% | +68.59% | +102.82% | 28.48B | |
| Weighted average by Cap. | +0.16% | +0.39% | +89.56% | +129.35% |
- Stock Market
- Stocks
- Stock
- Company InterMune Inc
Select your edition
All financial news and data tailored to specific country editions
